The global Amlodipine Besylate Market is driven by the high incidence of heart diseases globally, which creates a demand for the medication. The healthcare providers can increase or decrease the dose depending on the patient's history of heart attack, stroke, cardiac arrest, or stroke.

Amlodipine is also used to treat hypertension, which is caused by various factors such as smoking, diabetes, obesity, lack of physical activity, deficiency in vitamin D, stress, high salt, or alcohol intake levels. According to World Health Organization (WHO) data, around 1.13 billion people globally have hypertension, most (two-thirds) living in middle and low-income countries. Therefore, the increase in the number of patients will increase the demand for the product in the market.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/3752

Amlodipine besylate is a medication used to treat coronary artery disease and high blood pressure. It is a calcium channel blocker with antianginal and antihypertensive properties. The medication lowers blood pressure by relaxing the blood vessels that prevent heart attacks, strokes, and kidney problems. Amlodipine comes in 2.5 mg, 5mg, and 10mg tablets and is available as a generic drug. The tablet contains active and inactive ingredients, including dibasic calcium phosphate anhydrous, microcrystalline cellulose, magnesium stearate, and sodium starch glycolate.

However, amlodipine has certain side effects, including stomach pain, nausea, symptomatic hypotension, increased angina or myocardial infarction, dizziness, drowsiness, and liver problems. The alternative medications to amlodipine are also available in the market, such as clevidipine, nicardipine, and nifedipine, which may restrain the market growth over the forecast period.

The global amlodipine besylate market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The incidence of hypertension is increasing in the Asia Pacific region with the development of the economy in emerging countries like India and China and the aging of the population with changing lifestyle and food habits. Therefore, with the rising hypertensive patients, the market size of amlodipine besylate is also growing in the region.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/3752

Telehealth startup Ro has expanded its partnership with Pfizer to provide its generic versions of commonly prescribed cholesterol and blood pressure medications. Ro will supply Pfizer-produced generics of Norvasc (common brand of amlodipine besylate) through its virtual mail-order pharmacy. The medications will be made available through Ro's USD 5-per-month prescription drug service.

Some of the prominent players operating in the amlodipine besylate market are Pfizer, Mylan, Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Sun Pharmaceutical, Aurobindo Pharma, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, and MACLEODS.

The report provides a detailed overview of the amlodipine besylate market, changing dynamics, market segmentation, regional landscape, evaluation of the market based on the present and past data collected, historical, present, and projected market in terms of volume and value, recent trends and developments, competitive landscape, strategies adopted by key players, and products offered by them.

In conclusion, amlodipine besylate is an effective medication used to treat coronary artery disease and high blood pressure.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/3752

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse foe more reports…